−37JPY
−409.67 MJPY
11.43 BJPY
15.06 M
About TRANS GENIC INC
Sector
Industry
Headquarters
Fukuoka
Website
Employees (FY)
236
Founded
1998
ISIN
JP3635720000
FIGI
BBG000BLMV98
Trans Genic Inc. engages in the development, distribution, and licensing of genetically engineered animals and antibodies. It operates through the following segments: Contract Research Organization (CRO), Diagnostic Analysis, and Trans Genic Business Service (TGBS). The CRO segment deals with clinical trials, pharmacological tests, pharmacokinetic tests, non-clinical trials, and the production of genetically modified mice. The Diagnostic Analysis segment provides pathological diagnosis, gene analysis, and drug discovery support services for personalized medicine. The TGBS segment offers advice and support services related to the promotion of new business through mergers and acquisitions, business succession, and business revitalization. The company was founded on April 21, 1998 and is headquartered in Kumamoto, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 2342 is 227.00 JPY — it has increased by 0.44% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange TRANS GENIC INC stocks are traded under the ticker 2342.
TRANS GENIC INC is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track TRANS GENIC INC financials in yearly and quarterly reports right on TradingView.
Like other stocks, 2342 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TRANS GENIC INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 236.00 employees. See our rating of the largest employees — is TRANS GENIC INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TRANS GENIC INC EBITDA is 31.64 M JPY, and current EBITDA margin is 1.39%. See more stats in TRANS GENIC INC financial statements.